Korea University Guro Hospital — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Korea University Guro Hospital appears in 44 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials44

Recruiting shown4

Roles2

SourceClinicalTrials.gov

Clinical trials

44 shown

Quantitative Chest CT and Multi-Omics to Distinguish Asthma From COPD and Predict Treatment ResponseNCT07602192 · lead sponsor · 2025-12-22

Comparison of Clinical Efficacy Between Letrozole + Ribociclib and Fulvestrant + Letrozole + Ribociclib in Hormone Receptor Positive, HER2 Negative Metastatic Breast CancerNCT05816655 · lead sponsor · 2023-05-31

AI-Driven Precision Diagnostic System for Lung Cancer Based on Liquid BiopsyNCT07009769 · lead sponsor · 2024-10-16

SP Robotic Versus VATS Anatomical Pulmonary Resection for Patients With NSCLCNCT06202690 · lead sponsor · 2024-01-09

NOT_YET_RECRUITING

Impact of Maxigesic on Delirium After Minimally Invasive Lung Surgery in Elderly PatientsNCT05834569 · lead sponsor · 2023-06-15

Comparision of Various Biomarkers Between Peripheral and Pulmonary BloodNCT05587114 · lead sponsor · 2022-10-13

Alleviating Stress by Mobile Application' for DepressionNCT05312203 · lead sponsor · 2022-05-15

Home BIA Management System in Patients With Heart FailureNCT05177081 · lead sponsor · 2021-08-23

The Evaluation of Laser Lancing Devices in Adult Type 2 Diabetes PatientsNCT05251506 · lead sponsor · 2021-08-10

Immunogenicity After Revaccination With 23-valent Pneumococcal Polysaccharide Vaccine: Healthy Elderly People Versus Diabetic PatientsNCT04875858 · lead sponsor · 2021-05-01

Effects of APIXaban on BRAIN Protection in Patients With Sinus Rhythm and Heart Failure: APIXBRAIN-HF TrialNCT04696120 · lead sponsor · 2021-03-02

SLN Detection With Tc-MSA-ICG in Lung Cancer PatientsNCT05039905 · lead sponsor · 2021-02-15

Oncometabolic SurgeryNCT07437573 · lead sponsor · 2020-07-07

Multicenter Clinical Research for Early Diagnosis of Lung Cancer Using Blood Plasma Derived ExosomeNCT04529915 · lead sponsor · 2020-04-09

Identification of Integrin ab Expression in Lung Cancer PatientsNCT06167941 · lead sponsor · 2019-12-19

Retreatment With Epidermal Growth Factor Receptor(EGFR) Tyrosine Kinase Inhibitor in EGFR Mutation Positive PatientsNCT03382795 · lead sponsor · 2018-01-03

Subcostal Single-port Versus Intercostal Multi-port Robotic Lobectomy for Non-small Cell Lung CancerNCT07099105 · lead sponsor · 2017-01-01

Manidipine Versus Amlodipine in Patients With HypertensionNCT03106597 · lead sponsor · 2015-08-20

Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Among HIV-infected AdultsNCT03838497 · lead sponsor · 2015-04-02

Conventional Vaccine and Intradermal Vaccine Among HIV-infected Young SubjectsNCT02398097 · lead sponsor · 2011-11-01

An Adherence Study of Antipsychotic Medication in Outpatients With Schizophrenia or Schizoaffective DisorderNCT00861003 · lead sponsor · 2009-04-01

Progression to Impaired Glucose Tolerance and Type 2 Diabetes in the Korean People-based KNDP StudyNCT01034826 · lead sponsor · 2007-02-01

Efficacy and Safety of Lacidipine and Amlodipine on Blood Pressure in Korean ISH Patients Aged 60 to 80 YearsNCT00460915 · lead sponsor · 2007-01-01

Anesthesia and Non-small Cell Lung Cancer RecurrenceNCT06330038 · collaborator · 2024-08-05

Surgical TreAtment for Obesity Related Disease and Onco-Metabolic SurgeryNCT04284943 · collaborator · 2020-12-01

A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease PatientsNCT06329141 · collaborator · 2024-07-22

Efficacy of the Mobile Application for Prediction and Prevention of Mood Episode Recurrence Based on Machine LearningNCT05400785 · collaborator · 2022-05-27

Comparing Safety and Efficacy of Amlodipine Verses S Amlodipine in Patients With Essential HypertensionNCT04554303 · collaborator · 2020-10-28

Effect of Alogliptin/Pioglitazone on the Preservation of Long-term Beta-cell FunctionNCT02823808 · collaborator · 2017-07-01

Hospital-based Diabetes Prevention Study in KoreaNCT02981121 · collaborator · 2016-11-01

Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based TreatmentNCT03042520 · collaborator · 2016-08-01

Effect of Short-term Motilitone Therapy on Health-related Quality of Life in PD Patients With Gastrointestinal SymptomsNCT02775591 · collaborator · 2016-04-01

Efficacy and Safety of Adjuvant Pemetrexed Plus Cisplatin for Adenocarcinoma of LungNCT02498860 · collaborator · 2015-09-01

Fimasartan/Amlodipine Combination Phase IIINCT02152306 · collaborator · 2014-04-01

Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFαNCT01694264 · collaborator · 2012-09-01

A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential HypertensionNCT01518998 · collaborator · 2011-08-01

Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal WomenNCT01266213 · collaborator · 2010-12-01

A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapyNCT01258673 · collaborator · 2010-11-01

Asthma Control in Elderly Patients With MontelukastNCT01147510 · collaborator · 2010-07-01

Study of the Durability of Glycemic Control With NateglinideNCT00858013 · collaborator · 2009-04-24

Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic EventsNCT00886574 · collaborator · 2009-04-01

Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension PatientsNCT00922480 · collaborator · 2008-12-01

Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin TherapyNCT00474838 · collaborator · 2007-04-01

Korea National Diabetes ProgramNCT01212198 · collaborator · 2005-05-01

Drugs studied in this sponsor's trials

11 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Korea University Guro Hospital as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

placebo3

apixaban1

aspirin1

cilostazol1

cisplatin1

entecavir1

glimepiride1

goserelin1

placebo RxCUI 8375 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 3 trials apixaban RxCUI 1364430 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial aspirin RxCUI 1191 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial cilostazol RxCUI 21107 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial cisplatin RxCUI 2555 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial entecavir RxCUI 306266 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial glimepiride RxCUI 25789 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial goserelin RxCUI 50610 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial metformin RxCUI 6809 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial nateglinide RxCUI 274332 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial propofol RxCUI 8782 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial

Sponsor roles

lead sponsor23

collaborator21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.